1. Pig aortic endothelial and smooth-muscle cells in culture rapidly catabolize exogenous ATP, ADP or AMP. 2. In both cell types catabolism is due to Mg2+-stimulated ectoenzymes. 3. Inhibition and substrate-specificity studies suggest that both cell types possess three distinct ectonucleotidases, namely nucleoside triphosphatase (EC 3.6.1.15), nucleoside diphosphatase (EC 3.6.1.6) and 5'-nucleotidase (EC 3.1.3.5), as well as nucleoside diphosphate kinase (EC 2.7.4.6). 4. These ectonucleotidase systems could be of importance in the regulation of neurotransmission, blood platelet function and vasodilation.
Homogenates of vascular tissue can metabolize ADP to produce AMP and adenosine (Heyns et al., 1977; Lieberman et al., 1977) . More recent work has suggested that ADPase and 5'-nucleotidase activities are present as ectoenzymes on intact cultured vascular endothelial and smooth-muscle cells (Habliston et al., 1978; Cooper et al., 1979) , and that cultured endothelial cells can also catabolize exogenous ATP to adenosine (Dieterle et al., 1978; Dosne et al., 1978) . Preliminary work in our own laboratory has confirmed that intact endothelial and smooth-muscle cells in culture can sequentially degrade ATP to ADP, then to AMP and finally to adenosine . There has, however, been little attempt to characterize these ectoenzymic activities in terms of their substrate specificities or kinetics.
ADP is a powerful inducer of blood platelet aggregation, whereas adenosine is inhibitory, and it has therefore been suggested that the ADPase activity of endothelial cells is related to the resistance of endothelium to thrombogenesis (Lieberman et al., 1977; Glasgow et al., 1978) . Additionally, ATP and adenosine are powerful vasoactive agents (for review see Burnstock, 1979) . It is well established that ATP and ADP are secreted by stimulated blood platelets (Mills et al., 1968) . Other cell types, including mast cells (Cockcroft & Gomperts, 1979) , endothelium and vascular smooth muscle Vol. 190 adenine nucleotides when exposed to stimuli in vitro. Thus substrates for vascular ectonucleotidases will be present whenever platelets or vascular cells are stimulated, or after more extensive tissue damage, and the net biological effect of released nucleotides will depend on the relative activities of the nucleotidases present locally.
We have now characterized the ectonucleotidase activities of cultured aortic endothelial and smoothmuscle cells. Inhibition and substrate-specificity studies suggest that both cell types possess distinct nucleoside triphosphatase (EC 3.6.1.15), nucleoside diphosphatase (EC 3.6.1.6) and 5'-nucleotidase (EC 3.1.3.5) ectoenzymes as well as ecto-(nucleoside diphosphate kinase) (EC 2.7.4.6).
Materials and methods

Cell culture
Endothelial cells and smooth-muscle cells were isolated from aortas of 1-10-day-old pigs of the Babraham herd and cultured as previously described (Pearson et al., 1978) In these experiments dipyridamole (10uM), a potent inhibitor of adenosine uptake by endothelial cells (Pearson et al., 1978) , was added to prevent any uptake of [3H]adenosine formed. Under these conditions less than 0.5% of the 3H in the medium above endothelial cells at 60 min was found in inosine, hypoxanthine or IMP, indicating that production (if any) of these components takes place only intracellularly. With 120min incubations in the absence of dipyridamole, the amounts of products formed from 1 M-[3H]ATP were identical, except that the amount of [3Hladenosine found in the medium was decreased (with endothelial cells it was 22% of that found in the presence of dipyridamole, with smooth-muscle cells it was 73%) because of transport into the cells. The amounts of [3H]inosine and [3H]hypoxanthine present extracellularly were still very low (both were less than 0.5% of the total 3H in the medium above endothelial cells, and the amounts were respectively 10 and 2% of the total above smooth-muscle cells), confirming our earlier finding that adenosine taken up by vascular cells is predominantly converted into adenine nucleotides (Pearson et al., 1978 Vol. 190 fered saline (7.9 mM-P). f,-Glycerophosphate or p-nitrophenylphosphate had little or no effect at a concentration of 500,UM (Table 2) . Also, there was very little product inhibition (Table 2) . Catabolism was, however, inhibited by the addition of the other corresponding purine nucleotide (e.g. ATP catabolism was inhibited by GTP or ITP), as shown in Table 3 . (Fig. 4b ).
1980
The following compounds had no effect on adenine nucleotide catabolism in either cell type; pF,-P5-bis-(5'-adenosyl)pentaphosphate (up to 500,UM), ouabain (1 mM), the cell-penetrating thiol reagent N-ethylmaleimide (up to 100puM) and the non- penetrating reagent p-chloromercuribenzenesulphonic acid (up to 100puM).
Nucleoside diphosphate kinase activity During our studies on the substrate specificity of nucleotidase activity, the possible inhibitory effect of ATP on ADP catabolism was investigated and yielded an unexpected result. Added ATP stimulated endothelial ADP metabolism, with this stimulation being greater at 5min than 10min, presumably because of concomitant catabolism of the added ATP. When the distribution of 3H was studied, however, it was found that the increment in [3HIADP metabolism was exactly balanced by the formation of [3HIATP (Fig. 5) lOO,um-hydrox- ylamine, which has been reported to inhibit a similar ectoenzymic activity on blood platelets (Mustard et al., 1975) .
Discussion
Endothelial cells and smooth-muscle cells possess Mg2+_stimulated ectoenzymes that degrade exogenous ATP, ADP and AMP. We found no evidence that ATP was directly degraded to AMP, which suggests that these cells possess no ecto(ATPpyrophosphatase) (EC 3.6.1.8). Neither AMP nor adenosine was deaminated extracellularly. Although the apparent affinities of the smooth-muscle ectoenzymic activities were similar for ATP, ADP and AMP (Km approx. 100-1O5uM), the affinities of the endothelial enzymes differed (Km for ATP approx.
350pM, for ADP approx. 125,UM and for AMP 20-50pM) and there was a significantly lower Vmax for endothelial AMP catabolism than for any other activity. Little of these ectoenzymic activities was due to the presence of non-specific phosphatases. AMP catabolism by both cell types was potently and specifically inhibited by p[CH2IpA, which is generally recognized as an inhibitor of 5'-nucleotidase (Burger & Lowenstein, 1975) . Also, in both cell types p[NH]ppA was a much more potent inhibitor of ADP than of ATP catabolism, and ADP did not inhibit ATP catabolism, strongly suggesting that separate enzymes were responsible for ATP and ADP dephosphorylation. Finally, studies with phosphates of inosine and guanosine demonstrated that the corresponding purine nucleotide inhibited catabolism of the adenine nucleotide. Thus both endothelial and smooth-muscle cells in culture possess, as distinct Mg2+_stimulated ectoenzymes, nucleoside triphosphatase (EC 3.6.1.15, rather than ATPase, EC 3.6.1.3), nucleoside diphosphatase (EC 3.6.1.6) and 5'-nucleotidase (EC 3.1.3.5).
Two main questions arise from these observations: how do our results compare with those previously obtained for vascular or other cell types, and what may be the physiological relevance of such ectonucleotidases?
Previous observations on ectonucleotidases Ecto-ATPase activity has been detected on blood platelets, granulocytes, mast cells and several cell types in culture, including endothelial, smoothmuscle, neural and hepatic cells (Chambers et al., 1967; Tenney & Rafter, 1968; Trams & Lauter, 1974; Dieterle et al., 1978; Dosne et al., 1978; Chakravarty & Echetebu, 1978 of approx. 50,uM have been reported, where the enzyme activity has been distinguished from nonspecific ectophosphatase activity which is also present (De Pierre & Karnovsky, 1974; Smolen & Weissmann, 1978) .
There is more information about 5'-nucleotidase; the kinetics and substrate specificity of this ectoenzyme have been characterized on granulocytes, lymphocytes, cultured neural cells and isolated fat-cells (De Pierre & Karnovsky, 1974; Dornand et al., 1978; Stefanovic et al., 1976; Newby et al., 1975) . Km values of approx. 20pM have usually been found, and potent selective inhibition by p[CH2IpA.
More recently, Hayes et al. (1979) noted, in agreement with our results, that 5'-nucleotidase activity of cultured porcine endothelial cells was markedly lower than in cultured smooth-muscle cells. Because they have found that endothelial 5'-nucleotidase activity was higher and similar to that of smooth muscle in freshly isolated cells, they suggested that the low activity found after culture was due to some effect of the culture environment on endothelium (but not smooth muscle). It seems equally plausible, however, that the enzymic treatment used to isolate their endothelial (but not smooth-muscle) cells transiently stimulated activity, as has been found for prostaglandin synthesis (Ager et al., 1979) .
There is surprisingly little information on ectoADPase activity; although the degradation of ADP to adenosine by cultured vascular cells and isolated vascular tissue has been noted (Lieberman et al., 1977; Heyns et al., 1977; Habliston et al., 1978; Dosne et al., 1978; Cooper et al., 1979) (Baer & Drummond, 1968; Brashear & Ross, 1969) . Since then it has been shown that in perfused organs (particularly the lung) each nucleotide can be catabolized without cellular uptake (Ryan & Ryan, 1977; Crutchley et al., 1978) , and 5'-nucleotidase activity has been cytochemically localized to the plasma membrane of endothelium in lung, heart and skeletal muscle (Nakatsu & Drummond, 1972; Rubio et al., 1973; Ryan & Ryan, 1977 Adenosine and adenine nucleotides affect three important biological processes: neurotransmission, Vol. 190 blood-platelet function (and therefore haemostasis and thrombosis) and vasodilation. The ectonucleotidases that we have described could be of importance in regulating each of these three processes. Firstly, both ATP and adenosine have been postulated as neurotransmitters; ATP is released from nerve endings, and both compounds can modulate the response to other transmitters (see Burnstock, 1979; Paton, 1979) . The model for purinergic transmission proppsed by Burnstock (1972) requires the presence of ectonucleotidases, although he did not envisage these as a complete ectoenzymic system on the effector organ (i.e. smooth muscle).
Secondly, ADP induces platelet aggregation, whereas adenosine is inhibitory (Haslam & Rosson, 1975) . The role of the ecto-ADPase activity on endothelium was first envisaged as contributing to its antithrombotic properties (Heyns et al., 1974; Lieberman et al., 1977; Glasgow et al., 1978) , but this view has been challenged by Bunting et al. (1977) , who found that endothelial cells were not antithrombotic in a blood platelet bioassay system if their capacity to synthesize prostaglandins was blocked. We subsequently showed that endothelial cells can be stimulated to release nucleotides (particularly ATP) selectively in such a system, producing sufficient ADP (through ecto-ATPase activity) to aggregate blood platelets . Thus the net effect on thrombogenesis of a complete endothelial ectonucleotidase system (and also of nucleoside diphosphate kinase) is difficult to predict, especially as the relative proportions of nucleotides released will vary with their source; platelet degranulation releases ATP and ADP in approximately equal amounts (Mills et al., 1968) , whereas ATP is the major nucleotide released from damaged tissue.
Thirdly, both ATP and adenosine are powerful vasodilators (Burnstock, 1978) . Adenosine has been proposed as a local hormone with particular reference to coronary vasoregulation, where it appears in the myocardial tissue and blood in response to hypoxia (for review see Berne et al., 1979) . ATP is also found (Paddle & Burnstock, 1974) , but the sources of ATP and adenosine and the mechanisms by which they are released are not known. It has been supposed that myocardial cells regulate vascular tone by the release of adenosine in response to hypoxia, but the possibility that selective release of ATP by these cells occurs, with subsequent catabolism to adenosine by ectonucleotidases, has apparently not been rigorously tested. The release of adenosine itself from cells (whether cardiocytes or endothelium) in response to a stimulus such as hypoxia would require a dramatic change in intracellular adenine nucleotide metabolism, because the intracellular concentration of adenosine is normally extremely low. Outward transport of adenosine would then be needed, presumably by the uptake process operating in reverse. At present there is no evidence that strongly supports this; adenosine concentrations in myocardial cells are very low even when extracellular concentrations are high (Mustafa et al., 1975) , and inhibitors of adenosine transport do not prevent the appearance of adenosine outside myocardial cells in vitro (Mustafa, 1979) ; also they do not block, but potentiate post-hypoxic reactive hyperaemia in vivo (Parratt & Wadsworth, 1972) .
The alternative hypothesis merits consideration; Trams (1974) introduced the general concept of ATP translocation across cell membranes, and we have shown that selective release of ATP from vascular cells can occur . It is clear that the selective release of a very small proportion (<1%) of ATP from myocardial or vascular cells with catabolism to adenosine by ectonucleotidases could account for the amounts of adenosine found in blood after hypoxia. The vascular cells' ectonucleotidase system together with their adenosine-uptake system could therefore form a complete cycle for the local control of vascular tone by adenosine: release of precursor ATP (which could have short-lived vasodilatory activity itself), catabolism to active hormone, and termination of action by uptake.
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